| Blood Money |
Originally Published MX January/February 2005
BUSINESS NEWS
Swedish medical supply giant Gambro has agreed to divest its U.S. dialysis clinics business, Gambro Healthcare U.S., to DaVita Inc. (El Segundo, CA), the largest independent provider of dialysis services in the United States, for approximately $3.05 billion in cash. The move came after Gambro Healthcare pled guilty to felony charges and agreed to pay $350 million in criminal and civil fines to resolve federal healthcare fraud charges. The company's renal products and blood- component business units will be unaffected by the divestiture.